ABIONYX Pharma announces the completion of a contribution in kind to the company of 100% of the capital of IRIS Pharma Holding, fully compensated by the issue of new shares at a price of €3.60 per share to become a specialist of bioproducts in ophthalmolo
- Fichier: abionyx_pr_120621_69159.pdf